A-Labs Capital II Corp.
TTSXV:ALAB.P0.06
CAD
-0.02
(-25.00%)
ISIN
CA00167A1066
CUSIP
00167A106
Return %
Stock
S&P 500
1Y
9.09
14.20
3Y
-47.83
81.12
5Y
-47.83
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Semi-annual Revenue
CAD
•
in mil. unless spec.Semi-annual Earnings Per Share
CAD
•
in mil. unless spec.Semi-annual Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Sebastian Wahl
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Vancouver Canada
- IPO Date
- Mar 13, 2019
- Similar Companies
- Business
- A-Labs Capital II Corp. is a Canada-based capital pool company that focuses on the identification, evaluation, and acquisition of assets or operating businesses with a view to completing a Qualifying Transaction pursuant to Policy 2.4 of the TSX Venture Exchange. Incorporated in 2018 and headquartered in Vancouver, British Columbia, Canada, the company operates within the specialized finance and capital markets industry. As a capital pool entity with no commercial operations, the company’s core service offerings and operational activities comprise: identifying and evaluating commercial-stage and growth-oriented operating businesses; performing technical, regulatory, and corporate due diligence; structuring reverse takeovers, amalgamations, and share exchange agreements; managing treasury reserves and liquid cash assets; and conducting corporate finance activities, including initial public offerings, private placements, and short-term debt financings. While based in Canada, the company reviews prospective business combination targets across North America and international markets. In recent corporate developments, the company initiated a non-brokered private placement of common shares in September 2026 to fund ongoing working capital requirements, submitted an application in July 2025 for the resumption of trading on the TSX Venture Exchange, and executed a change of independent auditor alongside securing a non-convertible loan facility in March 2025. These strategic and financing actions followed the termination of a previously proposed acquisition of Orcanos Ltd., enabling A-Labs Capital II Corp. to refocus its capital resources on identifying new qualifying transaction opportunities.